Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Bevantolol

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Bevantolol
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Identifiers
  • (RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC20H27NO4
Molar mass345.439 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • O(c1ccc(cc1OC)CCNCC(O)COc2cc(ccc2)C)C
  • InChI=1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3 checkY
  • Key:HXLAFSUPPDYFEO-UHFFFAOYSA-N checkY
  (verify)

Bevantolol (INN) was a drug candidate for angina and hypertension that acted as both abeta blocker and acalcium channel blocker.[1][2] It wasdiscovered anddeveloped byWarner-Lambert[3] but in January 1989 the company announced that it had withdrawn theNew Drug Application; the company's chairman said: "Who needs the 30th beta blocker?"[4] As of 2016[update] it wasn't marketed in the US, UK, or Europe and the authors of a Cochrane review could find no product monograph for it.[5]

References

[edit]
  1. ^Frishman WH, Goldberg RJ, Benfield P (January 1988). "Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris".Drugs.35 (1):1–21.doi:10.2165/00003495-198835010-00001.PMID 2894292.
  2. ^Vaughan Williams EM (July 1987). "Bevantolol: a beta-1 adrenoceptor antagonist with unique additional actions".Journal of Clinical Pharmacology.27 (7):450–60.doi:10.1002/j.1552-4604.1987.tb03049.x.PMID 2888789.S2CID 72749127.
  3. ^McPherson EM (2007).Pharmaceutical Manufacturing Encyclopedia (3rd ed.). Burlington: Elsevier. pp. 618–619.ISBN 978-0-8155-1856-3.
  4. ^"Warner-Lambert Pipeline Narrowed to 40 Active Research Compounds".Pink Sheet. 30 January 1989.
  5. ^Wong GW, Boyda HN, Wright JM (March 2016)."Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension".The Cochrane Database of Systematic Reviews.3 (4) CD007451.doi:10.1002/14651858.CD007451.pub2.PMC 6486283.PMID 26961574.
β, non-selective
β1-selective
β2-selective
α1- + β-selective
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds


Stub icon

This article about anamine is astub. You can help Wikipedia byadding missing information.

Stub icon

Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Bevantolol&oldid=1329474711"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp